Bristol-Myers Squibb employees rode over 3,600 km across Europe for cancer patients

24 October 2017

UICC is very proud to report another successful edition of the European Country 2 Country 4 Cancer (C2C4C) ride organised in partnership with Bristol-Myers Squibb (BMS) to raise funds for cancer organisations across Europe.

Close to eighty BMS employees completed over 3,600 kilometres cycling through Germany, Switzerland, Italy, France, Spain, crossing the finish line in London on 25 September, 2017.  

This year’s edition saw the great involvement of eight key UICC member organisations across Europe who played an instrumental role in increasing awareness and amplifying fundraising efforts around the ride:

C2C4C 2017 member logos

Thanks to their active engagement, the different UICC members have raised over €70,000 in total with funds being used to support local activities aimed to reduce the cancer burden in their country.

RS17047_wagner_170925_1777_6454-scr.jpg
The BMS Bike riders with Cary Adams, UICC CEO and Jane Lyons, CEO of Cancer52 (click to zoom)

Jane Lyons, CEO of Cancer52 - a UICC member focusing on rare cancers in the UK – explains:

"Cancer52 was thrilled to be invited by UICC to be a partner in this ride, undertaken by so many dedicated bike riders from within the BMS team. We worked very happily alongside BMS in promoting the ride on social media and through our networks and we were very proud to be invited to the BMS employee event at their office in London on 25 September to welcome the riders home. This is a fantastic contribution to a small charity like us and will go towards our work on ensuring that the recommendations within the NHS England Cancer Strategy that are particularly relevant to rare and less common cancers are met."

We thank our Vanguard partner BMS for trusting UICC's work and look forward to continuing this unique and engaging initiative in 2018 together with our members from around the world.

Last update: 
Friday 7 June 2019
Share